Nurix Therapeutics, Inc. (NRIX)
22.16
-0.19
(-0.85%)
USD |
NASDAQ |
Oct 12, 16:00
22.55
+0.39
(+1.76%)
After-Hours: 04:45
Nurix Therapeutics Total Liabilities (Quarterly) : 226.99M for Aug. 31, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | 226.99M |
| May 31, 2026 | 132.91M |
| February 28, 2026 | 155.24M |
| November 30, 2025 | 163.82M |
| August 31, 2025 | 150.22M |
| May 31, 2025 | 143.95M |
| February 28, 2025 | 134.13M |
| November 30, 2024 | 148.44M |
| August 31, 2024 | 136.74M |
| May 31, 2024 | 140.34M |
| February 29, 2024 | 143.93M |
| November 30, 2023 | 164.05M |
| August 31, 2023 | 74.38M |
| May 31, 2023 | 90.70M |
| Date | Value |
|---|---|
| February 28, 2023 | 96.10M |
| November 30, 2022 | 116.36M |
| August 31, 2022 | 116.79M |
| May 31, 2022 | 127.57M |
| February 28, 2022 | 131.80M |
| November 30, 2021 | 137.80M |
| August 31, 2021 | 117.86M |
| May 31, 2021 | 119.80M |
| February 28, 2021 | 126.53M |
| November 30, 2020 | 106.07M |
| August 31, 2020 | 104.25M |
| May 31, 2020 | 274.80M |
| February 29, 2020 | 158.59M |
| November 30, 2019 | 53.57M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.62B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.195B |
| Shareholders Equity (Quarterly) | 968.31M |
| Debt to Equity Ratio | 0.0675 |
| Current Ratio | 8.442 |
| Net Debt Paydown Yield | -0.10% |